The health care giant's updated figure, disclosed last week, is nearly twice as large as the company's previous estimate of ...
The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.
UnitedHealth Group stock just saw its first insider buy of the year—and the first since the tragic murder of one of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback